The global home care testing market size is estimated to reach USD 17.95 billion by 2030, registering to grow at a CAGR of 9.36% from 2025 to 2030 according to a new report by Grand View Research, Inc. The growth of the market is attributed to factors, such as increasing demand for convenient and accessible healthcare solutions, growing focus on preventative healthcare and wellness, and technological advancements.An increase in technological advancements is another major factor contributing to the market growth. There have been significant advances in diagnostic technologies, such as digital imaging, molecular diagnostics, and lab-on-a-chip systems, which have enabled the development of innovative and effective at-home testing devices. In March 2023, Cue Health, a healthcare technology company, expanded its Cue Care platform with the launch of a suite of at-home diagnostic tests.
The tests are designed to provide individuals with quick and accurate results, allowing them to take control of their health and wellness. The new tests include a range of options, such as tests for COVID-19, influenza, and Respiratory Syncytial Virus (RSV).Furthermore, home care testing has helped to reduce healthcare costs. By enabling patients to conduct their own tests at home, healthcare providers can save on the cost of labor and infrastructure needed to perform testing in a healthcare setting. This can help make healthcare more affordable and accessible for patients, particularly those with chronic conditions requiring frequent testing. In addition, home care testing has increased accessibility for patients in rural or remote areas who may not have easy access to healthcare facilities.
By enabling patients to conduct tests at home, healthcare providers reach patients who might have difficulty accessing healthcare services.The pandemic has highlighted the importance of regular monitoring and early detection of diseases, which has boosted the demand for home care testing kits. Companies have been developing new technologies and solutions to address the growing demand for quick and accurate testing solutions. This has led to the development of a range of new home care testing products, including rapid antigen tests, antibody tests, and PCR tests, which have all been used to help diagnose and monitor COVID-19. In March 2023, Lucira Health received FDA authorization for its over-the-counter (OTC) flu and COVID-19 test. The test enables individuals to test themselves for COVID-19 and the flu at home, without the need for a healthcare provider.
Request a free sample copy or view report summary: Home Care Testing Market Report
Based on age, the geriatric segment captured the highest market share in 2024 due to the presence of the geriatric population coupled with a highincidence of chronic diseases.
Based on sample, the urine sample segment dominated the market in 2024. Advances in technology have led to more accurate and reliable urine sample testing, allowing for earlier detection and treatment of health conditions.
Based on test type, the infectious disease segment is expected to dominate the market in 2024. The growth of the segment is attributed to factors, such as increasing cases of infectious diseases globally and a high number of product approvals.
Based on distribution channel, the retail pharmacies segment is expected to dominate the market in 2024.These are easily accessible to consumers, with many located in convenient locations, such as shopping centers and grocery stores.
Based on product, the strip segment dominated the market in 2024. The strip tests are relatively inexpensive & easy to use and can be performed at home without the need for specialized equipment.
North America dominated the market and accounted for the largest revenue share of 33.71% in 2024 owing to the presence geriatric population and well-developed healthcare infrastructure.
Grand View Research has segmented the global home care testing market based on age, sample, test type, distribution channel, product, and region:
Home Care Testing Age Outlook (Revenue, USD Million, 2018 - 2030)
Pediatric
Adult
Geriatric
Home Care Testing Sample Outlook (Revenue, USD Million, 2018 - 2030)
Urine
Saliva
Blood
Others
Home Care Testing Test Type Outlook (Revenue, USD Million, 2018 - 2030)
HIV Test Kit
Diabetes and Glucose Tests
Cholesterol and Triglycerides Tests
Pregnancy Tests
Infectious Diseases Tests
Urinary Tract Infection Tests
Others
Home Care Testing Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
Retail Pharmacies
Supermarket/Hypermarket
Online Pharmacies
Home Care Testing Product Outlook (Revenue, USD Million, 2018 - 2030)
Strip
Cassette
Test Panel
Midstream
Dip Card
Others
Home Care Testing Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players of Home Care Testing Market
Abbott
BD
Quidel Corporation
BioSure
F. Hoffmann-La Roche Ltd.
Nova Biomedical
Siemens Healthcare GmbH
ACON Laboratories, Inc.
OraSure Technologies, Inc.
Chembio Diagnostics, Inc.
"The quality of research they have done for us has been excellent..."